SpecCheck
San Francisco
About SpecCheck
SpecCheck, backed by Y Combinator (W23), is an all-in-one solution that provides accurate prescription eyewear ordering and tracking, seamless billing, and streamlined communication between patients, eye doctors, and their lab partners. SpecCheck’s users work more efficiently and make fewer costly errors, increasing productivity and improving their overall workflow. Get in touch today for a product demo and to learn more!
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: Seed
- Last round: Seed (Oct 2023)
- Website: speccheckrx.com
- Phone: [email protected]
Industries & Categories
B2B, Health Care, SaaS, Software
Social Profiles
Canonical: https://fsome.com/organization/speccheck-51551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.